CVS formulary pushes biosimilars to the front of the market
By Mari Serebrov
Thursday, August 4, 2016
Ready or not, the biosimilar market is taking shape in the U.S. And the biggest shaper, at least early on, is the payer.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.